Bangladesh Pharmaceuticals Industries Association's new committee formed

Abdul Mukadir, Chairman and Managing Director of Incepta Pharmaceuticals Ltd, has been elected president of the Bangladesh Association of Pharmaceutical Industries (BAPI) for the next two years. 

Dr Md Zakir Hossain, Managing Director of Delta Pharma Ltd, has been elected Secretary General, and Muhammad Halimuzzaman, Deputy Managing Director & CEO of Healthcare Pharmaceuticals Ltd, has been elected Treasurer in the new committee of the Bangladesh Pharmaceuticals Industries Association for the next two years (2025-2026 & 2026-2027), according to a press release. 

Additionally, UNIMADE UNIHEALTH Pharmaceuticals Ltd's Chairman M Mosaddek Hossain has been elected Senior Vice-President, and RENATA PLC's Managing Director & CEO S Kaiser Kabir has been elected Vice-President. 

The 54th Annual General Meeting of BAPI was held on March 15, where the election for the new executive committee took place. 

The newly elected 20-member executive committee includes S M Shafiuzzaman (Managing Director, Hudson Pharmaceuticals Ltd), Md Harunur Rashid (Chairman and Managing Director, Globe Pharmaceuticals Ltd), MA Haider Hussain (Managing Director, Drug International Ltd), Rabbur Reza (CEO, Senevia Pharma PLC), Hasnin Muktadir (Vice Chairman, Incepta Pharmaceuticals Ltd - Vaccine Division), Md Abdur Razzaq (Managing Director, Nipro JMI Pharma Ltd), Simeen Rahman (Managing Director and Group CEO, SKF Pharmaceuticals Ltd), M Mohibuz Zaman (Chief Operating Officer, ACI Ltd), Md Nasser Shahriar Zahedi (Chairman, Radiant Pharmaceuticals Ltd), KSM Mostafizur Rahman (Managing Director, One Pharma Ltd), Md Mizanur Rahman (Executive Director, Square Pharmaceuticals Ltd - Chemical Division), Fahim Sinha (Director, The ACME Laboratories Ltd), Ahmed Imtiaz Hassan (Director, Aristopharma Ltd), Rafidul Haq (Managing Director, General Pharmaceuticals Ltd - Unit-2), and Arafat Zahid Ibn Shafi (Deputy Managing Director, Minara API Ltd).